CENTURY THERAPEUTICS, INC. |
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 3.11 USD | -1.27% |
|
+1.30% | -6.33% |
Chart calendar Century Therapeutics, Inc.
44066aab6224053459d14eac4d4f.e9Bv272CWCdFIRWezl8zYtr1PmJIfuDFaxK1ePIqVUM.I6oOkd_6IHEVSkbZ-AsFVZORDQkSKYGLAWf8Er16CnEs5kKU0fdrRRBLfg~4d2a62bb8a605ffadb7ec3434f5a825d
Upcoming events on Century Therapeutics, Inc.
Past events on Century Therapeutics, Inc.
| 2024-05-10 12:00 pm | American Society of Gene & Cell Therapy Meeting - Poster No - 1816 |
| 2024-05-10 12:00 pm | American Society of Gene & Cell Therapy Meeting - Poster No - 1815 |
| 2024-05-09 07:30 am | Q1 2024 Earnings Release |
| 2024-04-30 03:30 pm | Chardans Genetic Medicines Cell Therapy Manufacturing Summit - Panel |
| 2024-04-30 01:30 pm | Chardans Genetic Medicines Cell Therapy Manufacturing Summit - Fireside Chat |
| 2024-04-10 12:00 pm | American Association for Cancer Research Meeting - Abstract No - 6802 |
| 2024-04-09 12:00 pm | American Association for Cancer Research Meeting - Abstract No - 4009 |
| 2024-04-08 04:30 pm | American Association for Cancer Research Meeting - Abstract No - 3613 |
| 2024-04-08 12:00 pm | American Association for Cancer Research Meeting - Abstract No - 1916 |
| 2024-04-08 12:00 pm | American Association for Cancer Research Meeting - Abstract No - 1320 |
| 2024-04-07 04:30 pm | American Association for Cancer Research Meeting - Abstract No - 36 |
| 2024-03-26 01:30 pm | H.C. Wainwright Cell Therapy Virtual Conference |
| 2024-03-14 07:30 am | Q4 2023 Earnings Release |
| 2024-02-08 02:30 pm | Guggenheim Healthcare Talks Biotechnology Conference |
| 2023-12-11 10:30 am | CNTY-101 Phase 1 Trial Results Call |
| 2023-12-09 08:30 pm | American Society of Hematology Meeting - Abstract No:1654 |
| 2023-11-28 10:00 am | Piper Sandler Healthcare Conference - Fireside Chat |
| 2023-11-09 07:01 am | Q3 2023 Earnings Release |
| 2023-10-10 | Cell & Gene Meeting on the Mesa Conference |
| 2023-10-03 09:00 am | Chardan Genetic Medicines Conference - Fireside Chat |
Annual results
| Fiscal Period | December | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,00 0,00 - | 5,20 6,96 -25.34% | 2,24 3,82 -41.54% | 1,80 |
|
EBITDA Million USD | Released Forecast Spread | -91,1 -90,1 -1.11% | -125 -134 6.46% | 0,00 0,00 - | 0,00 |
|
EBIT Million USD | Released Forecast Spread | -94,9 -93,0 -2.07% | -134 -136 1.3% | -147 -133 -9.97% | -140 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -95,8 -94,2 -1.64% | -131 -133 1.87% | -135 -124 -8.96% | -130 |
|
Net income Million USD | Released Forecast Spread | -95,8 -93,3 -2.76% | -131 -134 2.12% | -137 -126 -8.33% | -133 |
|
EPS USD | Released Forecast Spread | -2,96 -3,21 7.91% | -2,27 -2,32 2.09% | -2,30 -2,09 -9.9% | -1,88 |
| Announcement Date | 17/03/22 | 16/03/23 | 14/03/24 | - |
Quarterly results
| Fiscal Period | December | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 | 2025 Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 1,06 6,67 -84.13% | 1,40 1,34 4.33% | 2,22 1,24 79.77% | 0,52 2,32 -77.53% | 1,72 1,47 17.01% | 0,10 1,56 -93.66% | 0,15 1,11 -86.61% | 0,27 1,89 -85.85% | 0,86 0,23 280% | 0,37 | 0,37 | 0,37 | 0,55 | 0,55 |
|
EBITDA Million USD | Released Forecast Spread | -27,6 -25,3 -9.34% | |||||||||||||
|
EBIT Million USD | Released Forecast Spread | -27,4 -30,7 10.5% | -31,4 -29,2 -7.32% | -31,7 -34,7 8.61% | -33,3 -35,3 5.74% | -32,1 -31,0 -3.53% | -30,9 -32,6 5.37% | -35,6 -32,3 -10.28% | -43,8 -35,2 -24.37% | -31,3 -32,4 3.37% | -34,0 | -36,3 | -38,3 | -39,2 | -41,5 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -37,5 -30,8 -21.89% | -31,0 -28,8 -7.71% | -30,7 -33,4 7.91% | -31,7 -34,3 7.85% | -30,1 -31,5 4.66% | -32,3 -32,3 -0.03% | -32,1 -31,3 -2.59% | -40,3 -34,1 -18.09% | -28,1 -31,3 10.46% | -31,7 | -33,9 | -36,2 | -37,3 | -39,9 |
|
Net income Million USD | Released Forecast Spread | -37,5 -25,9 -44.73% | -31,0 -29,0 -6.73% | -30,7 -34,3 10.23% | -31,7 -34,8 8.91% | -31,3 -30,4 -2.71% | -33,3 -31,8 -4.71% | -32,7 -31,6 -3.69% | -39,4 -32,8 -20.26% | -28,1 -31,3 10.45% | -31,7 | -33,9 | -36,2 | -37,3 | -39,9 |
|
EPS USD | Released Forecast Spread | -0,66 -0,46 -44.1% | -0,54 -0,50 -8% | -0,53 -0,59 9.44% | -0,55 -0,59 7.18% | -0,53 -0,52 -1.27% | -0,56 -0,54 -3.28% | -0,55 -0,51 -7.24% | -0,66 -0,55 -19.07% | -0,45 -0,51 12.45% | -0,47 | -0,48 | -0,50 | -0,53 | -0,52 |
| Announcement Date | 16/05/22 | 11/08/22 | 10/11/22 | 16/03/23 | 11/05/23 | 09/08/23 | 09/11/23 | 14/03/24 | 09/05/24 | - | - | - | - | - |
| 2024-05-15 | REPLIMUNE GROUP, INC.: Q4 2024 Earnings Release (Projected) |
| 2024-05-17 02:00 am | BIOARCTIC AB: Q1 2024 Earnings Release |
| 2024-05-20 | ALVOTECH: Q1 2024 Earnings Release |
| 2024-05-21 | CUREVAC N.V.: Q1 2024 Earnings Release (Projected) |
| 2024-05-21 | EXSCIENTIA PLC: Q1 2024 Earnings Release (Projected) |
| 2024-05-21 | EVOTEC SE: Q1 2024 Earnings Release |
| 2024-06-30 | IMMUNOVANT, INC.: Q4 2024 Earnings Release (Projected) |
| 2024-07-15 01:45 am | ADDLIFE AB: Q2 2024 Earnings Release |
| 2024-07-21 | MEDPACE HOLDINGS, INC.: Q2 2024 Earnings Release (Projected) |
| 2024-07-23 | SYNGENE INTERNATIONAL LIMITED: Q1 2025 Earnings Release (Projected) |
Past sector events for Century Therapeutics, Inc.
| Today | GNI GROUP LTD.: Q1 2024 Earnings Release |
| 2024-05-14 07:30 am | ABSCI CORPORATION: Q1 2024 Earnings Release |
| 2024-05-13 | BELITE BIO, INC: Q1 2024 Earnings Release |
| 2024-05-13 | POLARIS GROUP: Q1 2024 Earnings Release |
| 2024-05-13 04:30 pm | AEROVATE THERAPEUTICS, INC.: Q1 2024 Earnings Release |
| 2024-05-13 07:00 am | APOGEE THERAPEUTICS, INC.: Q1 2024 Earnings Release |
| 2024-05-12 07:00 pm | PRAXIS PRECISION MEDICINES, INC.: Q1 2024 Earnings Release |
| 2024-05-13 06:30 am | FORTREA HOLDINGS INC.: Q1 2024 Earnings Release |
| 2024-05-13 04:10 pm | CENTESSA PHARMACEUTICALS PLC: Q1 2024 Earnings Release |
| 2024-05-12 | BIOMEA FUSION, INC.: Q1 2024 Earnings Release (Projected) |
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- IPSC Stock
- Calendar Century Therapeutics, Inc.